Earlier Intervention in HS With COSENTYX® (secukinumab) and Long-Term Impact

Loading Events

« All Events

  • This event has passed.

Earlier Intervention in HS With COSENTYX® (secukinumab) and Long-Term Impact

July 9 @ 7:00 pm - 8:00 pm

Speaker: Leonardo Tjahjono, MD, FAAD Board-Certified Dermatologist Assistant Professor of Dermatology Co-Director of Hidradenitis Suppurativa Clinic Director of Inpatient Dermatology George Washington University School of Medicine Washington, DC

Moderator: Leon Kircik, MD, FAAD Medical Director, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai, New York, NY Indiana University Medical Center, Indianapolis, IN Medical Director Physicians Skin Care, PLLC, Louisville, KY DermResearch, PLLC, Louisville, KY Skin Sciences, PLLC, Louisville, KY

Please join us for our next IDF Educational Series Webinar: Earlier Intervention in HS With COSENTYX® (secukinumab) and Long-Term Impact This presentation will review the following key considerations in HS management: – When a patient with HS is ready for biologic therapy – What constitutes “moderate” HS – How patient-reported outcomes aid in HS severity assessment – What earlier intervention with biologic therapy can mean for patients

 

REGISTER

Details